Search results
Bull Market and Beyond: 2 Stocks Just Waiting to Soar | The Motley Fool
The Motley Fool· 2 days agoLet's consider two such stocks: Moderna (MRNA 7.13%) and DexCom (DXCM -1.65%). Moderna is one of the...
While shareholders of Moderna (NASDAQ:MRNA) are in the black over 5 years, those who bought a week...
Simply Wall St. via Yahoo Finance· 2 days agoLong term investing can be life changing when you buy and hold the truly great businesses. And we've...
If You'd Invested $1,000 in Moderna Stock 5 Years Ago, Here's How Much You'd Have Today
Motley Fool via Yahoo Finance· 6 days agoFive years ago, pharmaceutical company Moderna (NASDAQ: MRNA) was mostly unknown. It was developing...
Moderna Stock Seesaws After The FDA Throws It A Curveball
Investor's Business Daily· 5 days agoThe FDA was due to make a decision by May 12. Moderna emphasized the FDA has not said it found any...
Moderna and OpenAI Are Teaming Up, but Does That Make the Stock a Buy?
Motley Fool via Yahoo Finance· 3 days agoModerna (NASDAQ: MRNA) and OpenAI are collaborating to bring artificial intelligence (AI) to every...
Moderna Announces Update on Investigational RSV Vaccine
Morningstar· 5 days agoCAMBRIDGE, MA / ACCESSWIRE / May 10, 2024 / Moderna, Inc. (NASDAQ:MRNA) today announced it has been notified by the U.S. Food and Drug Administration (FDA) that due to administrative ...
FDA delays decision on Moderna RSV vaccine
BioPharma Dive via Yahoo Finance· 5 days agoThe regulator cited “administrative constraints,” rather than any issue with Moderna’s trial data, for missing a May 12 deadline, the company said.
Moderna (MRNA) Falls as FDA Extends Review Time for RSV Vaccine
Zacks via Yahoo Finance· 2 days agoShares of Moderna, Inc. MRNA were down 4.4% on May 10 after the company announced that the FDA has...
Moderna (MRNA) Falls as FDA Extends Review Time for RSV Vaccine
Zacks· 2 days agoFree Report) were down 4.4% on May 10 after the company announced that the FDA has delayed the review timeline for its mRNA-based, respiratory syncytial virus (RSV) vaccine, mRNA-1345.
US FDA pushes decision on Moderna's RSV vaccine to end of this month
Reuters via AOL· 5 days agoModerna's shares fell 3% to $119.02 in early trading. The Food and Drug Administration's move...